Skip to content

Clinical trials

Terminated Breast Neoplasms trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Status: Terminated Country / region: Italy Clear all

62 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20041
20052
20061
20073
20087
20093
20102
20114
20125
20132
20144
20157
20161
20174
20181
20191
20204
20215
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated62

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals6
Hoffmann-La Roche5
GlaxoSmithKline4
Pfizer4
Sanofi4
ETOP IBCSG Partners Foundation3
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS2
AVEO Pharmaceuticals, Inc.1
Allarity Therapeutics1
Amgen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms62
Neoplasm Metastasis4
Triple Negative Breast Neoplasms3
Brain Neoplasms2
Hereditary Sensory and Autonomic Neuropathies2
Ovarian Neoplasms2
Colonic Neoplasms1
Digestive System Neoplasms1
Endometrial Neoplasms1
Head and Neck Neoplasms1

Trials

Showing 1 to 25 of 62. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.